Zurueck zur Suche

Reporte zur Charge U016222

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
VA 2 NJ 1 CA 1

VAERS 2627910

MERCK & CO. INC. · HEP A (VAQTA) · Charge U016222

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
05.05.2023
Impfdatum
-
Beginn
17.02.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Patient was given expired Hep A vaccine expired on 2/6/23. Provider notified and he stated that he would notify the patient's parents of error once he reviewed the CDC recommendations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2627192

MERCK & CO. INC. · HEP A (VAQTA) · Charge U016222

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
05.05.2023
Impfdatum
-
Beginn
17.02.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Patient was given expired Hep A vaccine expired on 2/6/23. Provider notified and he stated that he would notify the patient's parents of error once he reviewed the CDC recommendations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2594956

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge U016222

gering
Staat
-
Alter
-
Geschlecht
F
Eingang
10.03.2023
Impfdatum
09.02.2023
Beginn
09.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired Havrix administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 5-year-old female patient who received HAV (Havrix) (batch number U016222, expiry date 6th February 2023) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 9th February 2023, the patient received Havrix and Havrix Pre-Filled Syringe Device. On 9th February 2023, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 01-MAR-2023 Reporter's Comments: The reporter consented to follow-up via email. Additional Supportive Information: The patient received an expired dose of Havrix, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2475311

MERCK & CO. INC. · HEP A (VAQTA) · Charge U016222

gering
Staat
NJ
Alter
44,0
Geschlecht
M
Eingang
11.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Patient was administered 0.5ml of pediatric Hepatitis A vaccine in a single dose vial then was administered 1.0ml of adult Hepatitis A vaccine in prefilled syringe.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
NKA
Vorherige Impfungen
-

VAERS 2360819

MERCK & CO. INC. · HEP A (VAQTA) · Charge U016222

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
07.07.2022
Impfdatum
20.06.2022
Beginn
20.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Underdose

Symptomtext

No additional adverse effects; adult patient received pediatric dose of VAQTA.; adult patient received pediatric dose of VAQTA.; This spontaneous report was received from a medical assistant and refers to a 59-year-old male patient. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 20-JUN-2022, the adult patient received one pediatric dose of Hepatitis A Vaccine, inactivated (VAQTA) lot # U016222 was confirmed to be valid with expiration date 06-FEB-2023, for prophylaxis (exact dose, route and site of administration were not reported). No additional adverse effects were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-